Table 1.
CD4 T cell evaluated | Permutation | Recipient strain | Islet entry | |
---|---|---|---|---|
Manipulation | ||||
3A9* | ||||
Non-activated | None | IP-HEL | No | |
Activated | None | IP-HEL | Yes | |
Activated | None | Non-IP-HEL | No | |
Activated | Anti-class II | IP-HEL | Reduced | |
Activated | Anti-ICAM-1 | IP-HEL | Reduced | |
Activated | Anti-class II + Anti-ICAM-1 | IP-HEL | Reduced | |
Activated | Anti-VCAM-1 | IP-HEL | Yes | |
Activated | Anti-PECAM-1 | IP-HEL | Yes | |
Activated + PTX | None | IP-HEL | Yes | |
Activated | Anti-IFN-γ | IP-HEL | Yes | |
B10.BR‡ | ||||
Non-activated | None | IP-HEL | No | |
Non-activated | None | Non-IP-HEL | No | |
Activated | None | IP-HEL | No | |
Activated | None | Non-IP-HEL | No | |
Activated | STZ | IP-HEL | No | |
Non-activated | Co-transfer with 3A9 | IP-HEL | Reduced | |
Activated | Co-transfer specific | IP-HEL | Yes | |
Activated + PTX | Co-transfer specific | IP-HEL | No | |
Activated | Co-transfer specific + anti-VCAM-1 | IP-HEL | No | |
Activated | Co-transfer specific + anti-IFN-γ | IP-HEL | Reduced | |
BDC2.5* | ||||
Non-activated | None | NOD.Rag-1-/- | Reduced | |
Activated | None | NOD.Rag-1-/- | Yes | |
Activated | None | B6.g7 | Yes | |
Activated | None | BALB/c | No | |
Activated | None | NOD.Class II-/- | No | |
Activated | Anti-Class II | NOD.Rag-1-/- | Reduced | |
Activated | None | NOD.ICAM-1-/- | Reduced | |
Activated | Anti-Class II | NOD.ICAM-1-/- | Reduced | |
Activated | Anti-CD44 | NOD.Rag-1-/- | Yes | |
Activated + PTX | None | NOD.Rag-1-/- | Yes | |
Activated | None | NOD. IFN-γR-/- | Reduced | |
B6.g7‡ | ||||
Non-activated | None | NOD.Rag-1-/- | No | |
Non-activated | None | B6.g7 | No | |
Activated | None | NOD.Rag-1-/- | No | |
Activated | None | B6.g7 | No | |
Activated | Co-transfer specific | NOD.Rag-1-/- | Yes | |
Activated + PTX | Co-transfer specific | NOD.Rag-1-/- | No | |
Activated | Co-transfer specific + anti-VCAM-1 | NOD.Rag-1-/- | No | |
Activated | Co-transfer specific | NOD. IFN-γR-/- | No |
3A9 is a CD4 T cell that recognizes the 48-62 peptide of HEL bound to I-Ak molecules. Cells were isolated from a T cell receptor transgenic mice and transferred directly (non-activated), or following a short period of activation with the peptide (activated). Recipients were mice that express HEL under the insulin promoter (IP-HEL) (37, 39). Results were identical in lightly irradiated and non irradiated mice. PTX refers to Pertussis toxin. STX refers to streptozotocin.
B10.BR refers to CD4 T cells from normal mice, incubated or not incubated with concanavalin A (ie activated and non-activated, respectively).
BDC2.5 refers to the diabetogenic CD4 T cells isolated from T cell receptor transgenic mice (36). Cells were activated by incubation with a mimotope peptide.
B6.g7 refers to CD4 T cells isolated from non-diabetic B6.g7 mice.